Optimizing CAR-T Cell Manufacturing Processes during Pivotal Clinical Trials
Author:
Funder
Novartis Pharmaceuticals
Publisher
Elsevier BV
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference21 articles.
1. Chimeric antigen receptor T-cell therapy for the community oncologist;Maus;Oncologist,2016
2. Global manufacturing of CAR T cell therapy;Levine;Mol. Ther. Methods Clin. Dev.,2016
3. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia;Kalos;Sci. Transl. Med.,2011
4. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia;Porter;N. Engl. J. Med.,2011
5. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N. Engl. J. Med.,2018
Cited by 100 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A quest for stakeholder synchronization in the CAR T-cell therapy supply chain;Frontiers in Bioengineering and Biotechnology;2024-08-08
2. A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells;Nature Biomedical Engineering;2024-06-04
3. Expanding the horizon of transient CAR T therapeutics using virus-free technology;Biotechnology Advances;2024-05
4. Sequencing of Anti-CD19 Therapies in the Management of Diffuse Large B-Cell Lymphoma;Clinical Cancer Research;2024-04-25
5. A quality-by-design approach to improve process understanding and optimise the production and quality of CAR-T cells in automated stirred-tank bioreactors;Frontiers in Immunology;2024-04-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3